Codex DNA Inc (DNAY)

6.80 +0.06  +0.89% NASDAQ Nov 26, 16:00 USD

Codex DNA Cash from Investing (TTM):

-0.588M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -0.588M
June 30, 2021 -0.263M
March 31, 2021 -0.293M
Dec. 31, 2020 -0.204M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

LENSAR Inc -0.303M
Eargo Inc -8.302M
Movano Inc -22.60M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -0.588M Sep 2021
Maximum -0.204M Dec 2020
Average -0.337M


Codex DNA acquires Eton Bioscience for ~$13M
SA Breaking News 11/10 06:17 ET
Codex DNA Acquires Eton Bioscience
Globe Newswire 11/09 16:15 ET
--Cowen Starts Codex DNA at Outperform
MT Newswires 07/13 06:53 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.